NICE TAG for dapagliflozin – Podcast
AstraZeneca have provided financial support for this blended learning series and have had no involvement in the content or speaker selection
Dr Yassir Javaid has recorded this podcast on behalf of the PCCS and it follows the review of the NICE TAG for dapagliflozin for the symptomatic treatment of HFrEF, providing an update on the new licence indication for dapagliflozin and focusing on the recommendations for its use within clinical practice in primary care.